Annual Net Margin
-1639.50%
-1408.72%-610.42%
December 31, 2023
Summary
- As of March 9, 2025, AVTX annual net profit margin is -1639.50%, with the most recent change of -1408.72% (-610.42%) on December 31, 2023.
- During the last 3 years, AVTX annual net margin has fallen by -691.60% (-72.96%).
- AVTX annual net margin is now -3941.38% below its all-time high of 42.68%, reached on December 31, 2017.
Performance
AVTX Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
N/A
September 30, 2024
Summary
- AVTX quarterly net profit margin is not available.
Performance
AVTX Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
AVTX Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -610.4% | - |
| 3 y3 years | -73.0% | - |
| 5 y5 years | -187.7% | - |
AVTX Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -610.4% | at low | ||
| 5 y | 5-year | -610.4% | at low | ||
| alltime | all time | -3941.4% | at low |
Avalo Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -1639.50%(+610.4%) | -1430.47%(-35.4%) |
| Sep 2023 | - | -2215.25%(+73.9%) |
| Jun 2023 | - | -1274.18%(-39.2%) |
| Mar 2023 | - | -2095.79%(+91.4%) |
| Dec 2022 | -230.78%(-85.2%) | -1095.09%(-5229.2%) |
| Sep 2022 | - | 21.35%(-101.7%) |
| Jun 2022 | - | -1257.21%(-33.1%) |
| Mar 2022 | - | -1879.88%(-78.6%) |
| Dec 2021 | -1563.10%(+64.9%) | -8765.30%(+580.3%) |
| Sep 2021 | - | -1288.52%(+152.7%) |
| Jun 2021 | - | -509.84%(-92.1%) |
| Mar 2021 | - | -6486.26%(+520.7%) |
| Dec 2020 | -947.90% | -1044.96%(-13.7%) |
| Sep 2020 | - | -1211.43%(+22.0%) |
| Jun 2020 | - | -992.60%(+29.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -766.78%(+320.2%) |
| Dec 2019 | -238.10%(-58.2%) | - |
| Sep 2019 | - | -182.46%(-59.2%) |
| Jun 2019 | - | -447.08%(+54.5%) |
| Mar 2019 | - | -289.32%(-428.6%) |
| Dec 2018 | -569.87%(-1435.2%) | 88.04%(-114.6%) |
| Sep 2018 | - | -603.80%(+381.0%) |
| Jun 2018 | - | -125.54%(+44.9%) |
| Mar 2018 | - | -86.62%(-37.4%) |
| Dec 2017 | 42.68%(-103.0%) | -138.42%(-285.1%) |
| Sep 2017 | - | 74.77%(-106.6%) |
| Jun 2017 | - | -1139.74%(+123.3%) |
| Mar 2017 | - | -510.31%(-43.6%) |
| Dec 2016 | -1428.60% | -905.35%(-52.8%) |
| Sep 2016 | - | -1918.75%(+254.2%) |
| Jun 2016 | - | -541.77% |
FAQ
- What is Avalo Therapeutics annual net profit margin?
- What is the all time high annual net margin for Avalo Therapeutics?
- What is Avalo Therapeutics annual net margin year-on-year change?
- What is the all time high quarterly net margin for Avalo Therapeutics?
What is Avalo Therapeutics annual net profit margin?
The current annual net margin of AVTX is -1639.50%
What is the all time high annual net margin for Avalo Therapeutics?
Avalo Therapeutics all-time high annual net profit margin is 42.68%
What is Avalo Therapeutics annual net margin year-on-year change?
Over the past year, AVTX annual net profit margin has changed by -1408.72% (-610.42%)
What is the all time high quarterly net margin for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly net profit margin is 88.04%